Healthcare
February 14, 2018 / 7:32 AM / a year ago

BRIEF-Natco Pharma Says Co's Mekaguda Facility Undergoing Routine U.S. FDA Inspection

1 Min Read

Feb 14 (Reuters) - Natco Pharma Ltd:

* NATCO PHARMA CLARIFIES ON NEWS ITEM ON US FDA INSPECTION AT CO’S MEKAGUDA FACILITY IN TELANGANA

* CO'S MANUFACTURING FACILITIES UNDERGO AUDITS FROM REGULATORY AUTHORITIES ON A REGULAR BASIS; INSPECTION IS NOT A MATERIAL EVENT‍​ Source text - bit.ly/2EozLQZ Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below